Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study

Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

(2020) Ida Pernicova et al.   Lancet Diabetes & Endocrinology

Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes

(2020) Ningjian Wang et al.   Frontiers in Endocrinology

The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2‐Year Follow‐Up Study

(2020) Leah T Braun et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Optimizing the Interaction of Exercise Volume and Metformin to Induce a Clinically Significant Reduction in Metabolic Syndrome Severity: A Randomised Trial

(2020) Joyce S. Ramos et al.   International Journal of Environmental Research and Public Health

Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats

(2020) Jie Li et al.   Journal of the American Heart Association

The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

(2020) Mahmoud S. Abdallah et al.   Neurotherapeutics

Effect of the Abnormal Expression of BMP-4 in the Blood of Diabetic Patients on the Osteogenic Differentiation Potential of Alveolar BMSCs and the Rescue Effect of Metformin: A Bioinformatics-Based Study

(2020) Chao Liang et al.   Biomed Research International

Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model

(2020) Chunhua Zhou et al.   Frontiers in Neuroscience

Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation

(2020) Xiaopeng Zhu et al.   BMJ Open Diabetes Research & Care

Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission

(2020) Frederick Vogel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy

(2019) Andrea Oßwald et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double‐blind, placebo‐controlled, multicenter trial: The MASTERS trial

(2019) R. Grace Walton et al.   AGING CELL

The role of an anti-diabetic drug metformin in the treatment of endocrine tumors

(2019) Shilpa Thakur et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry

(2019) Elena Valassi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Effect of Antidiabetic Treatment on Bone

(2019) J. JACKULIAK et al.   PHYSIOLOGICAL RESEARCH

Toward a Diagnostic Score in Cushing's Syndrome

(2019) Leah T. Braun et al.   Frontiers in Endocrinology

The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis

(2019) Xiaodong Yang et al.   PHARMACOLOGICAL RESEARCH

Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells

(2018) Kai Jin et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry

(2017) Christina M Berr et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21

(2016) Eun Kyung Kim et al.   MEDIATORS OF INFLAMMATION

Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology

(2016) Thomas Hart et al.   Scientific Reports

Complications of Cushing's syndrome: state of the art

(2016) Rosario Pivonello et al.   Lancet Diabetes & Endocrinology

Metformin—mode of action and clinical implications for diabetes and cancer

(2014) Ida Pernicova et al.   Nature Reviews Endocrinology

IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children

(2013) Alireza Morovat et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Metformin Stimulates FGF21 Expression in Primary Hepatocytes

(2012) Eva B. Nygaard et al.   Experimental Diabetes Research

Long-Term Cognitive Impairments and Attentional Deficits in Patients with Cushing's Disease and Cortisol-Producing Adrenal Adenoma in Remission

(2012) Oskar Ragnarsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats

(2011) Claudia Sedlinsky et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies

(2009) M Silvina Molinuevo et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes

(2009) Bernard Zinman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire

(2008) S M Webb et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome

(2008) Mirjam Christ-Crain et al.   FASEB JOURNAL

Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

(2008) Blerina Kola et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM